Pages that link to "Q73330039"

The following pages link to Thrombospondin-1, a natural inhibitor of angiogenesis, is present in vitreous and aqueous humor and is modulated by hyperglycemia (Q73330039):

Displaying 40 items.

• Cell type-specific post-transcriptional regulation of production of the potent antiangiogenic and proatherogenic protein thrombospondin-1 by high glucose (Q24304353) (← links)
• The vitreous glycoprotein opticin inhibits preretinal neovascularization (Q28863681) (← links)
• Opticin exerts its anti-angiogenic activity by regulating extracellular matrix adhesiveness (Q30524624) (← links)
• Modulation of thrombospondin 1 and pigment epithelium-derived factor levels in vitreous fluid of patients with diabetes (Q33642146) (← links)
• Lack of thrombospondin 1 and exacerbation of choroidal neovascularization (Q34122564) (← links)
• Ocular immune privilege: therapeutic opportunities from an experiment of nature (Q34282825) (← links)
• Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor (Q34477473) (← links)
• The eye's view of antigen presentation (Q34662378) (← links)
• Galectin-9-mediated protection from allo-specific T cells as a mechanism of immune privilege of corneal allografts. (Q34718313) (← links)
• Diabetes and retinal vascular dysfunction (Q35017752) (← links)
• Expression of pigment epithelium-derived factor and thrombospondin-1 regulate proliferation and migration of retinal pigment epithelial cells (Q35294211) (← links)
• Impaired expression of thrombospondin-1 in eyes with age related macular degeneration (Q35761496) (← links)
• Suppression of Thrombospondin-1 Expression During Uveal Melanoma Progression and Its Potential Therapeutic Utility (Q36054784) (← links)
• Understanding age-related macular degeneration (AMD): Relationships between the photoreceptor/retinal pigment epithelium/Bruch’s membrane/choriocapillaris complex (Q36083881) (← links)
• Preliminary study on electrophysiological changes after cellular autograft in age-related macular degeneration (Q36151822) (← links)
• Thrombospondin-1-Based Antiangiogenic Therapy (Q36417463) (← links)
• High glucose promotes retinal endothelial cell migration through activation of Src, PI3K/Akt1/eNOS, and ERKs (Q37016720) (← links)
• Reduction of endogenous angiogenesis inhibitors in Bruch's membrane of the submacular region in eyes with age-related macular degeneration (Q37090271) (← links)
• Inflammatory cytokine-specific alterations in retinal endothelial cell function (Q37150614) (← links)
• Thrombospondin-1 Deficiency Exacerbates the Pathogenesis of Diabetic Retinopathy (Q37283355) (← links)
• Mechanisms of immune privilege in the anterior segment of the eye: what we learn from corneal transplantation (Q37674078) (← links)
• Review of Ocular Immune Privilege in the Year 2010: Modifying the Immune Privilege of the Eye (Q37789750) (← links)
• Therapies using anti-angiogenic peptide mimetics of thrombospondin-1 (Q37963916) (← links)
• Thrombospondins: old players, new games (Q38124703) (← links)
• Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation (Q38190108) (← links)
• Negative regulators of angiogenesis: important targets for treatment of exudative AMD. (Q39416208) (← links)
• TGFbeta1 is involved in high glucose-induced accumulation of pericellular chondroitin sulphate in human endothelial cells (Q40520981) (← links)
• PEDF-deficient mice exhibit an enhanced rate of retinal vascular expansion and are more sensitive to hyperoxia-mediated vessel obliteration (Q42553869) (← links)
• Isolation and characterization of goat retinal microvascular endothelial cells (Q43137838) (← links)
• High glucose-induced alterations of extracellular matrix of human skin fibroblasts are not dependent on TSP-1–TGFβ1 pathway (Q44635154) (← links)
• Thrombospondin-1-deficient mice exhibit increased vascular density during retinal vascular development and are less sensitive to hyperoxia-mediated vessel obliteration (Q44675917) (← links)
• Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes (Q47130506) (← links)
• The prognosis of trabeculectomy in primary angle-closure glaucoma patients (Q60907313) (← links)
• Antiangiogenic cytokines as potential new therapeutic targets for resveratrol in diabetic retinopathy (Q62089583) (← links)
• Supernatants from human cytomegalovirus (HCMV)-infected retinal glial cells increase transepithelial electrical resistance in a cell culture model: evidence of HCMV immune escape in the eye? (Q73576865) (← links)
• Attenuation of retinal vascular development and neovascularization in transgenic mice over-expressing thrombospondin-1 in the lens (Q83324785) (← links)
• Current and emerging therapies for corneal neovascularization (Q89124983) (← links)
• Role of thrombospondin‑1 and thrombospondin‑2 in cardiovascular diseases (Review) (Q93173234) (← links)
• Negative Regulators of Angiogenesis, Ocular Vascular Homeostasis, and Pathogenesis and Treatment of Exudative AMD (Q93387980) (← links)
• Thrombospondin-1: A Key Protein That Induces Fibrosis in Diabetic Complications (Q97075318) (← links)